Completed
An ad hoc committee under the auspices of the National Academies of Sciences, Engineering, and Medicine will examine and report on challenges in supply, market competition, and regulation of infant formula in the United States. The project is sponsored by the US Department of Health and Human Services – Food and Drug Administration.
Featured publication
Consensus
·2024
Infant formula is a primary or supplementary source of nutrition for many infants in the U.S. Consequently, disruptions to the supply of infant formula can have a severe impact on infants' health and well-being. In late 2021 and early 2022, a recall of specific infant formula products, followed by a...
View details
Description
An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will examine and report on challenges in supply, market competition, and regulation of infant formula in the United States. Specifically, the committee will assess and evaluate:
- Characteristics of the U.S. infant formula market, including number, market share and other properties;
- Challenges in supply, or market competition with respect to such formula;
- Differences in infant formula marketed in the United States and infant formula marketed in the European Union, including with respect to nutritional content and applicable labeling and other regulatory requirements; and
- Other related information.
The committee will produce a report of its findings, conclusions, and recommendations, including recommendations for infant formula manufacturers, on measures to address supply and market competition in the United States as described in H.R. 2617 of the FY2023 Omnibus Bill.
Contributors
Committee
Chair
Member
Member
Member
Member
Member
Member
Member
Member
Member
Member
Member
Member
Vice Chair
Sponsors
Department of Health and Human Services
Staff
Katherine Delaney
Lead
Patricia Cuff
Lead
Melanie Arthur
Jen Stephenson
